Key result
Early administration of convalescent serum via subdural, intraspinal, or intravenous routes was historically reported to be of value in treating preparalytic cases of poliomyelitis.
Why the study?
Does convalescent serum improve outcomes in preparalytic cases of poliomyelitis?
Does convalescent serum improve outcomes in preparalytic cases of poliomyelitis?
Historical observations suggested the potential value of convalescent serum in the early stages of poliomyelitis.
Answers are grounded in this paper and cite their sources.
No current role in vaccinated populations; leaves open hypothesis for convalescent plasma in future outbreaks.
The brilliant observations of Levaditi and Landsteiner, Römer and Joseph, Flexner and Lewis, and Anderson and Frost that immunity or neutralizing substances to the poliomyelitis virus are present in the blood serum of recovered monkeys and human beings were followed fairly promptly by the reports of Netter and his associates in France and later by Amos and his co-workers in this country on the use of convalescent serum in the treatment of the disease. The French investigators used the subdural method of injection and believed that they had unquestionably proved the procedure to be of value. They stressed the time element particularly and urged that the injections be given in the earliest stages of the disease. The American observers employed the intraspinal and intravenous routes either directly into the blood vessels or indirectly by way of the subcutaneous tissues, and their results certainly justified their conclusions, that the earlier in
No takes yet. Share an insight, caveat, or question.
Shaw et al. (1925) conducted a review in Poliomyelitis. Convalescent serum was evaluated. Early administration of convalescent serum via subdural, intraspinal, or intravenous routes was historically reported to be of value in treating preparalytic cases of poliomyelitis.
Synapse has enriched 10 related papers. Consider them for comparative context: